{{Rsnum
|rsid=9370867
|Gene=MYLIP
|Chromosome=6
|position=16145094
|Orientation=plus
|GMAF=0.258
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYLIP
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 25.2 | 52.3 | 22.5
| HCB | 0.0 | 10.4 | 89.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.0 | 4.1 | 95.9
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 10.4 | 89.6
| CHD | 0.0 | 15.7 | 84.3
| GIH | 17.8 | 42.6 | 39.6
| LWK | 0.0 | 6.4 | 93.6
| MEX | 8.6 | 34.5 | 56.9
| MKK | 1.3 | 20.0 | 78.7
| TSI | 23.8 | 50.5 | 25.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21765216
|Title=The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans
|OA=1
}}

{{GET Evidence
|gene=MYLIP
|aa_change=Asn342Ser
|aa_change_short=N342S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9370867
|overall_frequency_n=6635
|overall_frequency_d=10758
|overall_frequency=0.61675
|n_genomes=48
|n_genomes_annotated=0
|n_haplomes=87
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}